UPDATE : Wednesday, February 20, 2019
‘We Want Healthcare’ introduces Lunit AI to its screening system by Lee Han-soo 2019-01-22 14:56
‘Appendicitis patients' prognosis remains similar if surgery is done within 24 hours’ by Lee Han-soo 2019-01-22 14:55
BMS, Ono Pharma wins more indication for Opdivo in EU by Lee Han-soo 2019-01-21 18:01
JW wins sales go-ahead for hemophilia A treatment by Lee Han-soo 2019-01-21 15:35
Novo Nordisk increases market share for mixed insulin in Korea by Lee Han-soo 2019-01-21 14:44
Sillajen releases interim results for combination cancer treatment in US by Lee Han-soo 2019-01-21 14:20
FDA OKs Samsung Bioepis’ first oncology medicine by Lee Han-soo 2019-01-21 11:43
Top Court’s ruling affects local companies’ base-altering strategies to avoid patents by Lee Han-soo 2019-01-18 16:36
OliX unveils new drug candidate for treating geographic atrophy by Lee Han-soo 2019-01-18 15:17
Celltrion wins patent dispute on Truxima by Lee Han-soo 2019-01-18 11:47
Over 1,000 bio-ventures set up in past 3 years by Lee Han-soo 2019-01-17 22:05
Daewoong to use cloud service for safe drug management by Lee Han-soo 2019-01-17 15:37
AMC develops tech to make infinite medical AI learning data by Lee Han-soo 2019-01-17 14:36
EN Cell to make Hanmi’s anti-cancer gene stem cell therapy by Lee Han-soo 2019-01-17 12:34
Bridge Biotherapeutics’ idiopathic pulmonary fibrosis treatment wins orphan drug status by Lee Han-soo 2019-01-17 11:04
Daewoong, Yonsei University to develop customized diagnosis, treatment system for cancer patients by Lee Han-soo 2019-01-16 17:19
Genexine, NeoImmuneTech wins FDA nod for clinical trials of GX-I7 by Lee Han-soo 2019-01-16 16:12
MSD gains additional indication for Keytruda by Lee Han-soo 2019-01-16 14:01
AMC to use 3D printing for complex cardiac anomaly surgery by Lee Han-soo 2019-01-16 13:21
NK Max submits plans for P1 clinical trial for immunotherapy in US by Lee Han-soo 2019-01-16 11:36
Back to Top